A Multi-scale Model of Hepcidin Promoter Regulation Reveals Factors Controlling Systemic Iron Homeostasis

Overview

Journal PLoS Comput Biol

Specialty Biology

Date 2014 Jan 7

PMID 24391488

Citations 10

Authors

Guillem Casanovas

Anashua Banerji

Flavia DAlessio

Martina U Muckenthaler

Stefan Legewie

Affiliations

Soon will be listed here.

Abstract

Systemic iron homeostasis involves a negative feedback circuit in which the expression level of the peptide hormone hepcidin depends on and controls the iron blood levels. Hepcidin expression is regulated by the BMP6/SMAD and IL6/STAT signaling cascades. Deregulation of either pathway causes iron-related diseases such as hemochromatosis or anemia of inflammation. We quantitatively analyzed how BMP6 and IL6 control hepcidin expression. Transcription factor (TF) phosphorylation and reporter gene expression were measured under co-stimulation conditions, and the promoter was perturbed by mutagenesis. Using mathematical modeling, we systematically analyzed potential mechanisms of cooperative and competitive promoter regulation by the transcription factors, and experimentally validated the model predictions. Our results reveal that hepcidin cross-regulation primarily occurs by combinatorial transcription factor binding to the promoter, whereas signaling crosstalk is insignificant. We find that the presence of two BMP-responsive elements enhances the steepness of the promoter response towards the iron-sensing BMP signaling axis, which promotes iron homeostasis in vivo. IL6 co-stimulation reduces the promoter sensitivity towards the BMP signal, because the SMAD and STAT transcription factors compete for recruiting RNA polymerase to the transcription start site. This may explain why inflammatory signals disturb iron homeostasis in anemia of inflammation. Taken together, our results reveal why the iron homeostasis circuit is sensitive to perturbations implicated in disease.

Citing Articles

Ex vivo STAT3 phosphorylation in circulating immune cells: a novel biomarker for early cancer diagnosis and response to anti-PD-1 therapy.

Lee S, Kim Y, Jeong S, Rho K, Noh J, Kim H Cancer Commun (Lond). 2024; 45(1):58-62.

PMID: 39568320 PMC: 11758149. DOI: 10.1002/cac2.12631.

Modeling Cellular Signaling Variability Based on Single-Cell Data: The TGFβ-SMAD Signaling Pathway.

Sarma U, Ripka L, Anyaegbunam U, Legewie S Methods Mol Biol. 2023; 2634:215-251.

PMID: 37074581 DOI: 10.1007/978-1-0716-3008-2_10.

Pharmacological Targeting of BMP6-SMAD Mediated Hepcidin Expression Does Not Improve the Outcome of Systemic Infections With Intra-Or Extracellular Gram-Negative Bacteria in Mice.

Hoffmann A, Valente de Souza L, Seifert M, von Raffay L, Haschka D, Grubwieser P Front Cell Infect Microbiol. 2021; 11:705087.

PMID: 34368018 PMC: 8342937. DOI: 10.3389/fcimb.2021.705087.

Inflammation Mediated Hepcidin-Ferroportin Pathway and Its Therapeutic Window in Breast Cancer.

Shibabaw T, Teferi B, Molla M, Ayelign B Breast Cancer (Dove Med Press). 2020; 12:165-180.

PMID: 33116818 PMC: 7585830. DOI: 10.2147/BCTT.S276404.

Exon Definition Facilitates Reliable Control of Alternative Splicing in the RON Proto-Oncogene.

Enculescu M, Braun S, Setty S, Busch A, Zarnack K, Konig J Biophys J. 2020; 118(8):2027-2041.

PMID: 32336349 PMC: 7175406. DOI: 10.1016/j.bpj.2020.02.022.

References

Denby C, Im J, Yu R, Pesce C, Brem R . Negative feedback confers mutational robustness in yeast transcription factor regulation. Proc Natl Acad Sci U S A. 2012; 109(10):3874-8. PMC: 3309721. DOI: 10.1073/pnas.1116360109. View

Andrews N . Disorders of iron metabolism. N Engl J Med. 1999; 341(26):1986-95. DOI: 10.1056/NEJM199912233412607. View

Kuhlman T, Zhang Z, Saier Jr M, Hwa T . Combinatorial transcriptional control of the lactose operon of Escherichia coli. Proc Natl Acad Sci U S A. 2007; 104(14):6043-8. PMC: 1851613. DOI: 10.1073/pnas.0606717104. View

Hengl S, Kreutz C, Timmer J, Maiwald T . Data-based identifiability analysis of non-linear dynamical models. Bioinformatics. 2007; 23(19):2612-8. DOI: 10.1093/bioinformatics/btm382. View

Goncalves E, Bucher J, Ryll A, Niklas J, Mauch K, Klamt S . Bridging the layers: towards integration of signal transduction, regulation and metabolism into mathematical models. Mol Biosyst. 2013; 9(7):1576-83. DOI: 10.1039/c3mb25489e. View

Camaschella C, Roetto A, Cali A, De Gobbi M, Garozzo G, Carella M . The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet. 2000; 25(1):14-5. DOI: 10.1038/75534. View

Corradini E, Meynard D, Wu Q, Chen S, Ventura P, Pietrangelo A . Serum and liver iron differently regulate the bone morphogenetic protein 6 (BMP6)-SMAD signaling pathway in mice. Hepatology. 2011; 54(1):273-84. PMC: 3277401. DOI: 10.1002/hep.24359. View

Nemeth E, Valore E, Territo M, Schiller G, Lichtenstein A, Ganz T . Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2002; 101(7):2461-3. DOI: 10.1182/blood-2002-10-3235. View

Meynard D, Kautz L, Darnaud V, Canonne-Hergaux F, Coppin H, Roth M . Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet. 2009; 41(4):478-81. DOI: 10.1038/ng.320. View

10.

Frank T, Cheong A, Okada-Hatakeyama M, Kholodenko B . Catching transcriptional regulation by thermostatistical modeling. Phys Biol. 2012; 9(4):045007. DOI: 10.1088/1478-3975/9/4/045007. View

11.

Peyssonnaux C, Zinkernagel A, Schuepbach R, Rankin E, Vaulont S, Haase V . Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J Clin Invest. 2007; 117(7):1926-32. PMC: 1884690. DOI: 10.1172/JCI31370. View

12.

Shea M, Ackers G . The OR control system of bacteriophage lambda. A physical-chemical model for gene regulation. J Mol Biol. 1985; 181(2):211-30. DOI: 10.1016/0022-2836(85)90086-5. View

13.

Feder J, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy D, Basava A . A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996; 13(4):399-408. DOI: 10.1038/ng0896-399. View

14.

Stelniec-Klotz I, Legewie S, Tchernitsa O, Witzel F, Klinger B, Sers C . Reverse engineering a hierarchical regulatory network downstream of oncogenic KRAS. Mol Syst Biol. 2012; 8:601. PMC: 3421447. DOI: 10.1038/msb.2012.32. View

15.

Bintu L, Buchler N, Garcia H, Gerland U, Hwa T, Kondev J . Transcriptional regulation by the numbers: models. Curr Opin Genet Dev. 2005; 15(2):116-24. PMC: 3482385. DOI: 10.1016/j.gde.2005.02.007. View

16.

Truksa J, Lee P, Beutler E . Two BMP responsive elements, STAT, and bZIP/HNF4/COUP motifs of the hepcidin promoter are critical for BMP, SMAD1, and HJV responsiveness. Blood. 2008; 113(3):688-95. PMC: 2628375. DOI: 10.1182/blood-2008-05-160184. View

17.

Buchler N, Gerland U, Hwa T . On schemes of combinatorial transcription logic. Proc Natl Acad Sci U S A. 2003; 100(9):5136-41. PMC: 404558. DOI: 10.1073/pnas.0930314100. View

18.

Andriopoulos Jr B, Corradini E, Xia Y, Faasse S, Chen S, Grgurevic L . BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet. 2009; 41(4):482-7. PMC: 2810136. DOI: 10.1038/ng.335. View

19.

Kautz L, Meynard D, Monnier A, Darnaud V, Bouvet R, Wang R . Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood. 2008; 112(4):1503-9. DOI: 10.1182/blood-2008-03-143354. View

20.

Rakemann T, Niehof M, Kubicka S, Fischer M, Manns M, Rose-John S . The designer cytokine hyper-interleukin-6 is a potent activator of STAT3-dependent gene transcription in vivo and in vitro. J Biol Chem. 1999; 274(3):1257-66. DOI: 10.1074/jbc.274.3.1257. View